Phyllis C Tien

Author PubWeight™ 103.88‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men. AIDS 2008 3.66
2 Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study. AIDS 2009 3.12
3 Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States. J Acquir Immune Defic Syndr 2011 2.65
4 Ten-year predicted coronary heart disease risk in HIV-infected men and women. Clin Infect Dis 2007 2.55
5 Conceptual framework for understanding the bidirectional links between food insecurity and HIV/AIDS. Am J Clin Nutr 2011 2.32
6 Short-term bone loss in HIV-infected premenopausal women. J Acquir Immune Defic Syndr 2010 1.87
7 Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons. Am J Kidney Dis 2010 1.84
8 Association of HIV infection, demographic and cardiovascular risk factors with all-cause mortality in the recent HAART era. J Acquir Immune Defic Syndr 2010 1.67
9 Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens. J Acquir Immune Defic Syndr 2007 1.66
10 The parametric g-formula to estimate the effect of highly active antiretroviral therapy on incident AIDS or death. Stat Med 2012 1.63
11 Prevalence and predictors of Toxoplasma seropositivity in women with and at risk for human immunodeficiency virus infection. Clin Infect Dis 2002 1.59
12 Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis. Int J Epidemiol 2013 1.57
13 Treatment-related changes in serum lipids and inflammation: clinical relevance remains unclear. Analyses from the Women's Interagency HIV study. AIDS 2013 1.43
14 Activation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virus. J Infect Dis 2010 1.42
15 Microalbuminuria is associated with all-cause and AIDS mortality in women with HIV infection. J Acquir Immune Defic Syndr 2010 1.37
16 Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment. J Acquir Immune Defic Syndr 2012 1.37
17 Time scale and adjusted survival curves for marginal structural cox models. Am J Epidemiol 2010 1.36
18 Regional adipose tissue and lipid and lipoprotein levels in HIV-infected women. J Acquir Immune Defic Syndr 2008 1.34
19 Clinical presentation and course of acute hepatitis C infection in HIV-infected patients. J Acquir Immune Defic Syndr 2006 1.32
20 Macrophage inflammatory markers are associated with subclinical carotid artery disease in women with human immunodeficiency virus or hepatitis C virus infection. Arterioscler Thromb Vasc Biol 2014 1.32
21 Obesity and immune cell counts in women. Metabolism 2007 1.31
22 Regional adipose tissue measured by MRI over 5 years in HIV-infected and control participants indicates persistence of HIV-associated lipoatrophy. AIDS 2010 1.29
23 Illicit drug use and HIV treatment outcomes in a US cohort. AIDS 2008 1.24
24 Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis. AIDS 2012 1.21
25 Decreased limb muscle and increased central adiposity are associated with 5-year all-cause mortality in HIV infection. AIDS 2011 1.19
26 Fracture incidence in HIV-infected women: results from the Women's Interagency HIV Study. AIDS 2010 1.19
27 Prevalence and correlates of elevated body mass index among HIV-positive and HIV-negative women in the Women's Interagency HIV Study. AIDS Patient Care STDS 2009 1.17
28 Factors associated with hepatitis C viremia in a large cohort of HIV-infected and -uninfected women. J Clin Virol 2008 1.15
29 The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women. J Acquir Immune Defic Syndr 2010 1.15
30 Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study. AIDS Care 2011 1.13
31 The association of bone mineral density with HIV infection and antiretroviral treatment in women. Antivir Ther 2007 1.13
32 Association of low level viremia with inflammation and mortality in HIV-infected adults. PLoS One 2011 1.09
33 Factors associated with seronegative chronic hepatitis C virus infection in HIV infection. Clin Infect Dis 2007 1.09
34 Associations of antiretroviral drug use and HIV-specific risk factors with carotid intima-media thickness. AIDS 2010 1.06
35 Self-perception of body fat changes and HAART adherence in the Women's Interagency HIV Study. AIDS Behav 2008 1.04
36 Comparisons of creatinine and cystatin C for detection of kidney disease and prediction of all-cause mortality in HIV-infected women. AIDS 2013 1.01
37 Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women. Clin Infect Dis 2007 1.01
38 Hepatic steatosis in HIV/hepatitis C coinfection: prevalence and significance compared with hepatitis C monoinfection. Hepatology 2005 1.01
39 Association of subclinical atherosclerosis with lipid levels amongst antiretroviral-treated and untreated HIV-infected women in the Women's Interagency HIV study. Atherosclerosis 2012 1.01
40 Urinary markers of kidney injury and kidney function decline in HIV-infected women. J Acquir Immune Defic Syndr 2012 1.01
41 Pre-existing albuminuria predicts AIDS and non-AIDS mortality in women initiating antiretroviral therapy. Antivir Ther 2011 1.01
42 Estimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progression. BMC Infect Dis 2007 1.00
43 Using marginal structural measurement-error models to estimate the long-term effect of antiretroviral therapy on incident AIDS or death. Am J Epidemiol 2009 0.98
44 Age-related skeletal muscle decline is similar in HIV-infected and uninfected individuals. J Gerontol A Biol Sci Med Sci 2011 0.96
45 Liver steatosis: investigation of opposed-phase T1-weighted liver MR signal intensity loss and visceral fat measurement as biomarkers. Radiology 2008 0.96
46 Association of hepatitis C virus seropositivity with inflammatory markers and heart failure in persons with coronary heart disease: data from the Heart and Soul study. J Card Fail 2009 0.94
47 Increased Fracture Incidence in Middle-Aged HIV-Infected and HIV-Uninfected Women: Updated Results From the Women's Interagency HIV Study. J Acquir Immune Defic Syndr 2015 0.94
48 Respiratory motion-corrected proton magnetic resonance spectroscopy of the liver. Magn Reson Imaging 2008 0.93
49 Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women. J Infect Dis 2007 0.93
50 Vitamin D insufficiency may impair CD4 recovery among Women's Interagency HIV Study participants with advanced disease on HAART. AIDS 2013 0.92
51 Insulin resistance and cognition among HIV-infected and HIV-uninfected adult women: the Women's Interagency HIV Study. AIDS Res Hum Retroviruses 2011 0.92
52 Correlates of prevalent hypertension in a large cohort of HIV-infected women: Women's Interagency HIV Study. AIDS 2007 0.91
53 Association of regional body composition with bone mineral density in HIV-infected and HIV-uninfected women: women's interagency HIV study. J Acquir Immune Defic Syndr 2012 0.90
54 Association of HIV infection, hepatitis C virus infection, and metabolic factors with liver stiffness measured by transient elastography. J Infect Dis 2013 0.90
55 Longitudinal anthropometric patterns among HIV-infected and HIV-uninfected women. J Acquir Immune Defic Syndr 2008 0.89
56 Serum albumin and short-term risk for mortality and cardiovascular disease among HIV-infected veterans. AIDS 2013 0.89
57 A chronic kidney disease risk score to determine tenofovir safety in a prospective cohort of HIV-positive male veterans. AIDS 2014 0.89
58 The effects of opiate use and hepatitis C virus infection on risk of diabetes mellitus in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr 2010 0.88
59 Mechanisms for the Negative Effects of Internalized HIV-Related Stigma on Antiretroviral Therapy Adherence in Women: The Mediating Roles of Social Isolation and Depression. J Acquir Immune Defic Syndr 2016 0.88
60 Regional anthropometry changes in antiretroviral-naïve persons initiating a Zidovudine-containing regimen in Mbarara, Uganda. AIDS Res Hum Retroviruses 2011 0.88
61 HIV/hepatitis C virus coinfection ameliorates the atherogenic lipoprotein abnormalities of HIV infection. AIDS 2014 0.84
62 Marginal structural models for case-cohort study designs to estimate the association of antiretroviral therapy initiation with incident AIDS or death. Am J Epidemiol 2012 0.84
63 Metabolic syndrome, diabetes, and cardiovascular risk in HIV. Curr HIV/AIDS Rep 2014 0.83
64 Does HIV infection promote early kidney injury in women? Antivir Ther 2013 0.83
65 Association of HIV, hepatitis C virus and liver fibrosis severity with interleukin-6 and C-reactive protein levels. AIDS 2015 0.83
66 Adipose tissue and metabolic factors associated with steatosis in HIV/HCV coinfection: histology versus magnetic resonance spectroscopy. J Acquir Immune Defic Syndr 2010 0.83
67 Gonadotropin and sex steroid levels in HIV-infected premenopausal women and their association with subclinical atherosclerosis in HIV-infected and -uninfected women in the women's interagency HIV study (WIHS). J Clin Endocrinol Metab 2013 0.82
68 Association of HIV clinical disease progression with profiles of early immune activation: results from a cluster analysis approach. AIDS 2013 0.82
69 T-cell activation, both pre- and post-HAART levels, correlates with carotid artery stiffness over 6.5 years among HIV-infected women in the WIHS. J Acquir Immune Defic Syndr 2014 0.82
70 Resolution of hepatitis C virus-induced steatosis improves tolerability of antiretroviral drugs associated with hepatotoxicity in an HIV-infected individual. J Infect Dis 2008 0.81
71 Hormonal contraception and metabolic outcomes in women with or at risk for HIV infection. J Acquir Immune Defic Syndr 2009 0.81
72 Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults. AIDS 2017 0.81
73 Liver diffusivity in healthy volunteers and patients with chronic liver disease: comparison of breathhold and free-breathing techniques. J Magn Reson Imaging 2011 0.80
74 The association between diet and physical activity on insulin resistance in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr 2013 0.80
75 Vitamin D and insulin resistance in non-diabetic women's interagency HIV study participants. AIDS Patient Care STDS 2013 0.80
76 Hormonal contraception and HIV-positive women: metabolic concerns and management strategies. J Midwifery Womens Health 2008 0.78
77 Anthropometric measures and cognition in middle-aged HIV-infected and uninfected women. The Women's Interagency HIV Study. J Neurovirol 2013 0.78
78 Antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007 0.78
79 Liver Fibrosis Linked to Cognitive Performance in HIV and Hepatitis C. J Acquir Immune Defic Syndr 2016 0.78
80 Antiretroviral therapy modifies the genetic effect of known type 2 diabetes-associated risk variants in HIV-infected women. AIDS 2014 0.77
81 Relationship of vitamin D, HIV, HIV treatment, and lipid levels in the Women's Interagency HIV Study of HIV-infected and uninfected women in the United States. J Int Assoc Provid AIDS Care 2014 0.77
82 Teriparatide treatment of osteoporosis in an HIV-infected man: a case report and literature review. AIDS 2015 0.76
83 Association of hepatitis C with markers of hemostasis in HIV-infected and uninfected women in the women's interagency HIV study (WIHS). J Acquir Immune Defic Syndr 2013 0.76
84 Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected Women. J Acquir Immune Defic Syndr 2016 0.75
85 Enhanced liver fibrosis marker as a noninvasive predictor of mortality in HIV/hepatitis C virus-coinfected women from a multicenter study of women with or at risk for HIV. AIDS 2016 0.75
86 Prevalence and predictors of low muscle mass in HIV/viral hepatitis coinfection. AIDS 2016 0.75
87 Sex differences in the association of HIV infection with hepatic steatosis. AIDS 2016 0.75
88 Brief Report: Association of Adipokines With Bone Mineral Density in HIV-Infected and HIV-Uninfected Women. J Acquir Immune Defic Syndr 2016 0.75
89 Increased glucose transporter-1 EXPRESSION on intermediate monocytes from HIV-infected women with subclinical cardiovascular disease. AIDS 2016 0.75
90 Association of serum albumin and aspartate transaminase with 5-year all-cause mortality in HIV/hepatitis C virus coinfection and HIV monoinfection. AIDS 2017 0.75
91 Investigating the effects of metabolic dysregulation on hair follicles: a comparison of HIV-infected women with and without central lipohypertrophy. Int J Dermatol 2013 0.75
92 Antiretroviral-treated HIV-infected women have similar long-term kidney function trajectories as HIV-uninfected women. AIDS Res Hum Retroviruses 2013 0.75
93 Association of markers of hemostasis with death in HIV-infected women. J Acquir Immune Defic Syndr 2014 0.75
94 Changes in weight and weight distribution across the lifespan among HIV-infected and -uninfected men and women. Medicine (Baltimore) 2016 0.75
95 The association of self-perception of body fat changes and quality of life in the Women's Interagency HIV Study. AIDS Care 2013 0.75
96 Higher Body Mass Index is Associated with Greater Proportions of Effector CD8+ T cells Expressing CD57 in Women Living with HIV. J Acquir Immune Defic Syndr 2017 0.75
97 Controlled attenuation parameter and MR spectroscopy-measured liver steatosis are discordant in HIV-infected adults with high body mass. AIDS 2017 0.75